Intervention

SHR-3045 Injection

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid ArthritisNCT07233655 · 2026-01-19

ACTIVE_NOT_RECRUITING

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy SubjectsNCT07200596 · 2025-10-08

A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy SubjectsNCT06883695 · 2025-04-08

Common conditions

Moderate to Severe Active Rheumatoid Arthritis1 Rheumatoid Arthritis1 Rheumatoid Arthritis (RA)1

Leading sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd3

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.